STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: LinkMed’s portfolio company Ortoviva’s new Distractor system for spinal surgery, which recently received CE approval, has successfully undergone clinical testing. This means the company has passed another important milestone on the path towards a commercial launch. The clinical tests were conducted by M.D. Svante Berg of the Stockholm Spine Center, Sweden’s largest and one of Scandinavia’s leading spine clinics, located at Löwenströmska Hospital in Upplands Väsby outside of Stockholm.
